Canada Specialty Pharmacy Market
Market Report I 2025-04-01 I 350 Pages I Data Bridge Market Research
The Canada specialty pharmacy market is expected to reach USD 13.94 billion by 2030 from USD 7.39 billion in 2024, growing at a substantial CAGR of 11.2% in the forecast period of 2025 to 2030.
Market Segmentation:
Canada Specialty Pharmacy Market Segmentation, By Service Type (Clinical Services, Operational Services, and Other Services), Type (Large Pharmacy Benefit Manager (PBM) and Small- Independent Pharmacy Service Providers), Condition (Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Osteoarthritis, Infertility, HIV, Pulmonary Hypertension, Immune Deficiency, Anemia, Hemophilia, Psoriasis, Cystic Fibrosis, Ulcerative Colitis, Crohn's Disease, Juvenile Idiopathic Arthritis, Growth Hormone Deficiencies, Hepatitis C Virus, and Others) - Industry Trends & Forecast to 2030
Overview of the Canada specialty pharmacy market are:
Driver
- Increasing prevalence of chronic and rare diseases
Restrain
- Stringent regulatory framework
Opportunity
- Emerging markets of specialty pharmacies
Market Players:
The key market players for Canada specialty pharmacy market are listed below:
- McKesson Canada (Canada)
- Sobeys Inc. (Canada)
- Rexall Pharmacy Group Ltd. (Canada)
- Bayshore HealthCare (Canada)
- PHARMASAVE (Canada)
- 360Care Denman Pharmacy (Canada)
- Abby Pharmacy (Canada)
- PharmaChoice Canada Inc. (Canada)
- Anchor Compounding Pharmacy (Canada)
- Andreen's Pharmacy (Canada)
- Balanced Health Integrative Pharmacy (Canada)
- Bains Pharmacy (Canada)
- NKS Health (Canada)
- Concord Specialty Pharmacy (Canada)
- BioScript Solutions (Canada)
- McCallum Pharmacy (Canada)
- Lovell Drugs (Canada)
- Create Compounding Limited (Canada)
- Dynasty Pharmacy (Canada)
- Resident Care Pharmacy (Canada)
- Pace Pharmacy (Canada)
- Northmount Pharmacy and Compounding Lab (Canada)
- Victoria Compounding Pharmacy (Canada)
- Aaronson's Compounding Pharmacy (Canada)
- Total Pharmacy (Canada)
- Riverviewguardian.ca (Canada)
- Shoppers Drug Mart Specialty Health Network Inc. (Canada)
- Meds West Ltd. (Canada)
- Rx Connect (Canada)
- London Drugs (Canada)
- Sentrex Health Solutions (Canada)
- Medicine Centre (Canada)
- Aurora Health Care (U.S.)
- Omnicell Inc. (U.S.)
- Onpharm-United (Canada)
- Mountain Health CO-OP (U.S.)
- SRx Health (Canada)
- Compounding Pharmacy New Westminster - Longevity Pharmacy (Canada)
- City Life Pharmacy (Canada)
- Omnicare Pharmacy (U.S.)
- Budget Pharmacy (Canada)
- Torani and Haddad Pharmacy Spec-Pharma (Canada)
- West End Pharmacy (Canada)
- Brunskill Pharmacy (Canada)
- Extend Pharmacy (Canada)
- Sherman Specialty Pharmacy (Canada)
- Quiick Medicine (Canada)
- Pratt's Compounding Pharmacy (Canada)
- Allcures Pharmacy (Canada)
- Alpine Drug Mart I.D.A. (Canada)
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE CANADA SPECIALTY PHARMACY MARKET 14
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 SERVICES LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 VENDOR SHARE ANALYSIS 27
2.11 SECONDARY SOURCES 28
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 34
4.1 PESTAL ANALYSIS 35
4.2 PORTERS FIVE FORCES ANALYSIS 36
5 CANADA SPECIALTY PHARMACY MARKET: REGULATIONS 37
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASING PREVALENCE OF CHRONIC AND RARE DISEASES 40
6.1.2 INCREASING GERIATRIC POPULATION 40
6.1.3 INCREASING NUMBER OF DISTRIBUTION CHANNELS FOR SPECIALITY DRUGS 41
6.2 RESTRAINTS 42
6.2.1 STRINGENT REGULATORY FRAMEWORK 42
6.2.2 LACK OF SKILLED PHARMACISTS 43
6.3 OPPORTUNITIES 44
6.3.1 EMERGING MARKETS OF SPECIALTY PHARMACIES 44
6.3.2 RISING E-PHARMACIES FACILITIES 44
6.4 CHALLENGES 45
6.4.1 LACK OF AWARENESS AMONG CONSUMERS ABOUT SPECIALTY PHARMACIES 45
6.4.2 INSUFFICIENT FUNDING FOR SPECIALITY PHARMACIES 45
7 CANADA SPECIALTY PHARMACY MARKET, BY TYPE 46
7.1 OVERVIEW 47
7.2 LARGE PHARMACY BENEFIT MANAGER (PBM) 50
7.2.1 MANUFACTURER-OWNED SPECIALTY PHARMACIES 50
7.2.2 OWNED SPECIALTY PHARMACIES 50
7.3 SMALL-INDEPENDENT PHARMACY SERVICE PROVIDERS 50
8 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE 51
8.1 OVERVIEW 52
8.2 CLINICAL SERVICES 55
8.2.1 COMPOUNDING 56
8.2.2 AUTO-REFILLS/REFILLS 56
8.2.3 BLISTER PACKAGING 56
8.2.4 MEDICAL CONSULTATIONS 56
8.2.5 CARE MANAGEMENT 56
8.2.6 PATIENT ADHERENCE PROGRAMS 56
8.2.7 HEALTH CARE PROVIDER ACCESS 56
8.2.8 CLINICAL OUTCOME MEASURES 56
8.2.9 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) PROGRAMS 56
8.3 OPERATIONAL SERVICES 57
8.3.1 SUPPLY CHAIN MANAGEMENT 57
8.3.2 CARE COORDINATION 57
8.3.3 INSURANCE NAVIGATION 57
8.3.4 PATIENT ASSISTANCE 57
8.3.5 PLAN OPTIMIZATION 57
9 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION 59
9.1 OVERVIEW 60
9.2 CANCER 63
9.3 RHEUMATOID ARTHRITIS 63
9.4 MULTIPLE SCLEROSIS 64
9.5 OSTEOARTHRITIS 64
9.6 INFERTILITY 64
9.7 HIV 64
9.8 PULMONARY HYPERTENSION 64
9.9 IMMUNE DEFICIENCY 64
9.10 ANEMIA 64
9.11 HEMOPHILIA 64
9.12 PSORIASIS 64
9.13 CYSTIC FIBROSIS 64
9.14 ULCERATIVE COLITIS 65
9.15 CROHN'S DISEASE 65
9.16 JUVENILE IDIOPATHIC ARTHRITIS 65
9.17 GROWTH HORMONE DEFICIENCIES 65
9.18 HEPATITIS C VIRUS 65
9.19 OTHERS 65
10 CANADA SPECIALTY PHARMACY MARKET, COMPANY LANDSCAPE 66
10.1 COMPANY SHARE ANALYSIS: GLOBAL 66
11 SWOT ANALYSIS 67
12 COMPANY PROFILES 68
12.1 MCKESSON CANADA 68
12.1.1 COMPANY SNAPSHOT 68
12.1.2 SERVICE PORTFOLIO 68
12.1.3 RECENT DEVELOPMENTS 68
12.2 SOBEYS INC. 69
12.2.1 COMPANY SNAPSHOT 69
12.2.2 SERVICE PORTFOLIO 69
12.2.3 RECENT DEVELOPMENTS 69
12.3 REXALL PHARMACY GROUP LTD. 70
12.3.1 COMPANY SNAPSHOT 70
12.3.2 SERVICE PORTFOLIO 70
12.3.3 RECENT DEVELOPMENTS 70
12.4 BAYSHORE HEALTHCARE 72
12.4.1 COMPANY SNAPSHOT 72
12.4.2 SERVICE PORTFOLIO 72
12.4.3 RECENT DEVELOPMENTS 73
12.5 PHARMASAVE 74
12.5.1 COMPANY SNAPSHOT 74
12.5.2 SERVICE PORTFOLIO 74
12.5.3 RECENT DEVELOPMENTS 74
12.6 AARONSON'S COMPOUNDING PHARMACY 76
12.6.1 COMPANY SNAPSHOT 76
12.6.2 SERVICE PORTFOLIO 76
12.6.3 RECENT DEVELOPMENTS 76
12.7 ANCHOR COMPOUNDING PHARMACY 77
12.7.1 COMPANY SNAPSHOT 77
12.7.2 SERVICE PORTFOLIO 77
12.7.3 RECENT DEVELOPMENTS 78
12.8 ABBY PHARMACY 79
12.8.1 COMPANY SNAPSHOT 79
12.8.2 SERVICE PORTFOLIO 79
12.8.3 RECENT DEVELOPMENTS 80
12.9 AURORA HEALTHCARE 81
12.9.1 COMPANY SNAPSHOT 81
12.9.2 SERVICE PORTFOLIO 81
12.9.3 RECENT DEVELOPMENTS 82
12.10 ALLCURES PHARMACY 83
12.10.1 COMPANY SNAPSHOT 83
12.10.2 SERVICE PORTFOLIO 83
12.10.3 RECENT DEVELOPMENTS 84
12.11 ALPINE DRUG MART I.D.A. 85
12.11.1 COMPANY SNAPSHOT 85
12.11.2 PRODUCT PORTFOLIO 85
12.11.3 RECENT DEVELOPMENTS 86
12.12 ANDREEN'S PHARMACY 87
12.12.1 COMPANY SNAPSHOT 87
12.12.2 SERVICE PORTFOLIO 87
12.12.3 RECENT DEVELOPMENTS 88
12.13 BRUNSKILLPHARMACY 89
12.13.1 COMPANY SNAPSHOT 89
12.13.2 SERVICE PORTFOLIO 89
12.13.3 RECENT DEVELOPMENTS 90
12.14 BAINS PHARMACY 91
12.14.1 COMPANY SNAPSHOT 91
12.14.2 PRODUCT PORTFOLIO 91
12.14.3 RECENT DEVELOPMENTS 92
12.15 BIOSCRIPT SOLUTIONS 93
12.15.1 COMPANY SNAPSHOT 93
12.15.2 SERVICE PORTFOLIO 93
12.15.3 RECENT DEVELOPMENTS 94
12.16 BUDGET PHARMACY 95
12.16.1 COMPANY SNAPSHOT 95
12.16.2 SERVICE PORTFOLIO 95
12.16.3 RECENT DEVELOPMENTS 95
12.17 BALANCED HEALTH INTEGRATIVE PHARMACY 96
12.17.1 COMPANY SNAPSHOT 96
12.17.2 SERVICE PORTFOLIO 96
12.17.3 RECENT DEVELOPMENTS 97
12.18 COMPOUNDING PHARMACY NEW WESTMINSTER - LONGEVITY PHARMACY 98
12.18.1 COMPANY SNAPSHOT 98
12.18.2 SERVICE PORTFOLIO 98
12.18.3 RECENT DEVELOPMENTS 98
12.19 CITY LIFE PHARMACY 99
12.19.1 COMPANY SNAPSHOT 99
12.19.2 SERVICE PORTFOLIO 99
12.19.3 RECENT DEVELOPMENTS 100
12.20 CREATE COMPOUNDING LIMITED 101
12.20.1 COMPANY SNAPSHOT 101
12.20.2 SERVICE PORTFOLIO 101
12.20.3 RECENT DEVELOPMENTS 101
12.21 CONCORD SPECIALTY PHARMACY 102
12.21.1 COMPANY SNAPSHOT 102
12.21.2 SERVICE PORTFOLIO 102
12.21.3 RECENT DEVELOPMENTS 102
12.22 360CARE DENMAN PHARMACY 103
12.22.1 COMPANY SNAPSHOT 103
12.22.2 SERVICE PORTFOLIO 103
12.22.3 RECENT DEVELOPMENTS 104
12.23 DYNASTY PHARMACY 105
12.23.1 COMPANY SNAPSHOT 105
12.23.2 SERVICE PORTFOLIO 105
12.23.3 RECENT DEVELOPMENTS 105
12.24 EXTEND PHARMACY 106
12.24.1 COMPANY SNAPSHOT 106
12.24.2 SERVICE PORTFOLIO 106
12.24.3 RECENT DEVELOPMENTS 106
12.25 LONDON DRUGS 107
12.25.1 COMPANY SNAPSHOT 107
12.25.2 SERVICE PORTFOLIO 107
12.25.3 RECENT DEVELOPMENTS 107
12.26 LOVELL DRUGS 108
12.26.1 COMPANY SNAPSHOT 108
12.26.2 SERVICE PORTFOLIO 108
12.26.3 RECENT DEVELOPMENTS 109
12.27 MEDICINE CENTRE 110
12.27.1 COMPANY SNAPSHOT 110
12.27.2 SERVICE PORTFOLIO 110
12.27.3 RECENT DEVELOPMENTS 110
12.28 MOUNTAIN HEALTH CO-OP 111
12.28.1 COMPANY SNAPSHOT 111
12.28.2 SERVICE PORTFOLIO 111
12.28.3 RECENT DEVELOPMENTS 111
12.29 MEDS WEST LTD. 112
12.29.1 COMPANY SNAPSHOT 112
12.29.2 SERVICE PORTFOLIO 112
12.29.3 RECENT DEVELOPMENTS 112
12.30 MCCALLUM PHARMACY 113
12.30.1 COMPANY SNAPSHOT 113
12.30.2 SERVICE PORTFOLIO 113
12.30.3 RECENT DEVELOPMENTS 115
12.31 NORTHMOUNT PHARMACY AND COMPOUNDING LAB 116
12.31.1 COMPANY SNAPSHOT 116
12.31.2 SERVICE PORTFOLIO 116
12.31.3 RECENT DEVELOPMENTS 116
12.32 NKS HEALTH 117
12.32.1 COMPANY SNAPSHOT 117
12.32.2 SERVICE PORTFOLIO 117
12.32.3 RECENT DEVELOPMENTS 118
12.33 ONPHARM-UNITED 119
12.33.1 COMPANY SNAPSHOT 119
12.33.2 SERVICE PORTFOLIO 119
12.33.3 RECENT DEVELOPMENTS 120
12.34 OMNICARE PHARMACY 121
12.34.1 COMPANY SNAPSHOT 121
12.34.2 SERVICE PORTFOLIO 121
12.34.3 RECENT DEVELOPMENTS 121
12.35 OMNICELL INC. 122
12.35.1 COMPANY SNAPSHOT 122
12.35.2 REVENUE ANALYSIS 122
12.35.3 SERVICE PORTFOLIO 123
12.35.4 RECENT DEVELOPMENT 124
12.36 PHARMACHOICE CANADA INC. 126
12.36.1 COMPANY SNAPSHOT 126
12.36.2 SERVICE PORTFOLIO 126
12.36.3 RECENT DEVELOPMENTS 128
12.37 PRATT'S COMPOUNDING PHARMACY 129
12.37.1 COMPANY SNAPSHOT 129
12.37.2 SERVICE PORTFOLIO 129
12.37.3 RECENT DEVELOPMENTS 131
12.38 PACE PHARMACY 132
12.38.1 COMPANY SNAPSHOT 132
12.38.2 SERVICE PORTFOLIO 132
12.38.3 RECENT DEVELOPMENTS 132
12.39 QUIICK MEDICINE 133
12.39.1 COMPANY SNAPSHOT 133
12.39.2 SERVICE PORTFOLIO 133
12.39.3 RECENT DEVELOPMENTS 134
12.40 RX CONNECT 135
12.40.1 COMPANY SNAPSHOT 135
12.40.2 SERVICE PORTFOLIO 135
12.40.3 RECENT DEVELOPMENTS 135
12.41 RIVERVIEWGUARDIAN.CA 136
12.41.1 COMPANY SNAPSHOT 136
12.41.2 SERVICE PORTFOLIO 136
12.41.3 RECENT DEVELOPMENTS 137
12.42 RESIDENT CARE PHARMACY 138
12.42.1 COMPANY SNAPSHOT 138
12.42.2 SERVICE PORTFOLIO 138
12.42.3 RECENT DEVELOPMENTS 139
12.43 SHERMANSPECIALTY PHARMACY 140
12.43.1 COMPANY SNAPSHOT 140
12.43.2 SERVICE PORTFOLIO 140
12.43.3 3.43.3. RECENT DEVELOPMENTS 142
12.44 SHOPPERS DRUG MART SPECIALTY HEALTH NETWORK INC. 143
12.44.1 COMPANY SNAPSHOT 143
12.44.2 SERVICE PORTFOLIO 143
12.44.3 RECENT DEVELOPMENTS 143
12.45 SRX HEALTH 144
12.45.1 COMPANY SNAPSHOT 144
12.45.2 SERVICE PORTFOLIO 144
12.45.3 RECENT DEVELOPMENTS 145
12.46 SENTREX HEALTH SOLUTIONS 146
12.46.1 COMPANY SNAPSHOT 146
12.46.2 SERVICE PORTFOLIO 146
12.46.3 RECENT DEVELOPMENTS 146
12.47 TORANI AND HADDAD PHARMACY SPEC- PHARMA 147
12.47.1 COMPANY SNAPSHOT 147
12.47.2 SERVICE PORTFOLIO 147
12.47.3 RECENT DEVELOPMENTS 148
12.48 TOTAL PHARMACY 149
12.48.1 COMPANY SNAPSHOT 149
12.48.2 SERVICE PORTFOLIO 149
12.48.3 RECENT DEVELOPMENTS 150
12.49 VICTORIA COMPOUNDING PHARMACY 151
12.49.1 COMPANY SNAPSHOT 151
12.49.2 SERVICE PORTFOLIO 151
12.49.3 RECENT DEVELOPMENTS 152
12.50 WEST END PHARMACY 153
12.50.1 COMPANY SNAPSHOT 153
12.50.2 SERVICE PORTFOLIO 153
12.50.3 RECENT DEVELOPMENTS 154
13 QUESTIONNAIRE 155
14 RELATED REPORTS 158
?
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.